Amgen | Contract Pharma
Biosimilars Clinical Trials | Amgen Biosimilars
Inside Amgen's Push for Greater Diversity in Clinical Trials | Amgen
Amgen deploys StudyTeam enrollment software
Amgen scientists' rapid work to challenge the undruggable KRAS G12C mutation in cancer
Amgen unveils its KRas inhibitor in human clinical trials
A Strategy for Making Clinical Trials More Successful | Amgen
Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
Clinical Trials | Amgen
Amgen taps Syapse to infuse real-world data into its cancer clinical trial designs | Fierce Biotech
Biosimilars Clinical Trials | Amgen Biosimilars
Biosimilars Clinical Trials | Amgen Biosimilars
Clinical Trials | Amgen
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine
Clinical Trials | Amgen
Clinical Trials | Amgen
How Amgen Is Taking An Adaptive Approach To Clinical Trials
Amgen Careers - “I always feel valued for my work and understand how I fit into the bigger picture,” says Tom Morley, Senior Clinical Trial Manager, of his experience on our Global
Clinical Trials | Amgen
Amgen - Wikipedia
AMGEN at the American College of Cardiology's (ACC) Annual Meeting
Amgen shares hit after analysts expose buried FDA trial halt | Fierce Biotech
FDA approves Amgen drug for lung cancer with specific mutation
Amgen unveils its KRas inhibitor in human clinical trials
Cytokinetics | Clinical Trials | ALS | Heart Failure | SMA
